Juan Giles, M.D.
Gynecologist at IVI Valencia and Clinical Researcher at the INCLIVA Institute
IVI Valencia
Juan Giles, M.D.
Biografía
Dr. Juan Giles, MD, is an attending gynecologist at IVI Valencia and clinical researcher at the INCLIVA Institute. He is licentiate in Medicine & Surgery by the University Complutense of Madrid from June 1994. He performed his residency training in Obstetrics and Gynaecology in the Hospital Universitario Severo Ochoa, Madrid, from 1998 to 2002. He also obtained the Level III of ultrasonography in Obstetrics & Gynaecology by the Sociedad Española de Obstetricia y Ginecología (SEGO) in 2002, the European Certificate of Gynaecological Endoscopic Surgery in Clermnont Ferrand in 2005 and the ESHRE Certification for Reproductive Endoscopic Surgeons in 2017.
Read more
Formación
| BS | University Complutense of Madrid, Spain (1994) |
| MD | University Complutense of Madrid, Spain (2005) |
| Residency | Hospital Severo Ochoa (2002), Spain |
| Training | Instituto Valenciano de Infertilidad, University of Valencia |
| Master | University of Valencia (2005) |
| Certificate surgery | University Clermont Ferrand ( 2005) |
| ESHRE | Certification for Reproductive Endoscopic Surgeons (2017) |
Publicaciones
-
Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis
Cobo A Coello A De Los Santos MJ Giles J Pellicer A Remohi J Garcia Velasco J
Reproductive BioMedicine OnlineAvailable online 8 January 2021 -
Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone.
Labarta E Mariani G Paolelli S Rodriguez-Varela C Vidal C Giles J Bellver J Cruz F Marzal A Celada P Olmo I Alamá P Remohí J Bosch E
Hum Reprod. 2020 Dec 19:deaa322. doi: 10.1093/humrep/deaa322. Online ahead of print. -
A 5-year Multicenter Randomized Controlled Trial of In Vitro Fertilization with Personalized Blastocyst Transfer versus Frozen or Fresh Transfer.
Simon C Gomez C Cabanillas S I Vladimirov Castillón J Giles J Boynukalin D Findikli N Bahceci M Ortega I Vidal C Funabiki M Izquierdo A Lopez L S Portela Frantz N Kulmann N Taguchi S Labarta E Colucci F S Mackens X Santamar´?a E Munoz S Barrera García-Velasco JA Fernandez M Ferrando M Ruiz M Valbuena D for the ERA-RCT Study Consortium Group
Reproductive BioMedicine OnlineIn press, journal pre-proofAvailable online 15 June 2020 -
Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
Cobo A Giles J Paolelli S Pellicer A Remohí J García-Velasco JA
Fertil Steril. 2020 Mar 4. pii: S0015-0282(19)32556-7. doi: 10.1016/j.fertnstert.2019.11.017. [Epub ahead of print] -
Activin and inhibin A in predicting outcome of pregnancies of unknown location after ART
Giles J Vidal C Pellicer A Bosch E
Medicina Reproductiva y Embriología Clínica, 5(3):109-115, 2018. -
GnRH antagonist for endometrial priming in an oocyte donation programme: a prospective, randomized controlled trial
Vidal C Giles J Garrido N Remohí J Simón C Bellver J Pellicer A
Reprod Biomed Online, 37(4):415-424, 2018. -
Small-sized follicles could contribute to high-order multiple pregnancies: outcomes of 6552 intrauterine insemination cycles.
Giles J Cruz M González-Ravina C Caligara C Martínez JC Vergara V Requena A
Reprod Biomed Online, 37(5):549-554, 2018. -
Small-sized follicles could contribute to high-order multiple pregnancies: outcomes of 6552 intrauterine insemination cycles.
Giles J Cruz M González-Ravina C Caligara C Prados N Martínez JC Vergara V Requena A
Reprod Biomed Online, 37(5):549-554, 2018. -
Activin and inhibin A in predicting outcome of pregnancies of unknown location after ART
Giles J Vidal C Pellicer A Bosch E
Medicina Reproductiva y Embriología Clínica, 5(3):109-115, 2018. -
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.
Rubio C Bellver J Rodrigo L Castillón G Guillén A Vidal C Giles J Ferrando M Cabanillas S Remohí J Pellicer A Simón C
Fertil Steril. 2017 May;107(5):1122-1129. doi: 10.1016/j.fertnstert.2017.03.011. Epub 2017 Apr 19.
Read more
Presentations
- Giles J Cruz M Alamá P Laura Caracena Vidal C Bosch E P-863 PROGNOSTIC FACTORS OF OVARIAN RESPONSE AFTER FOLLICULAR PROTOCOL WITH MPA TRIGGER WITH GnRH AGONIST.. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Vidal C Giles J Mollá Robles G De los Santos MJ Remohí J Cobo A P-542 LESSONS LEARNED FROM A 10 YEARS CRYOEMBRYO VITRIFICATION PROGRAM: THE AGE OF THE OOCYTE MATTERS.. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Giles J Alama P Gamiz P Vidal C Badia P Bosch E O-010 Can serve Medroxiprogesterone acetate (MPA) as gonadotropin adjuvant instead of GnRH antagonist during ovarian stimulation (OS) in oocyte donation (OD) cycles trigger with GnRH agonist? . Presented at the 36th annual meeting of the European Society of Human Reproduction and Embryology, Copenhagen,Denmark, July 5-8, 2020
- Giles J Mercader A Rubio C Vidal C Alegre L Trabalon M Meseguer M P-332 PGT-A (preimplantational genetic screening) in patients with partial X monosomy using own oocytes: is a suitable indication?. Presented at the 35th annual meeting of the European Society of Human Reproduction and Embryology, Vienna, Austria, 14-16 October 2019
- Ángel Martin Vidal C Rodrigo L Mercader A Rubio C Giles J Remohí J De los Santos MJ P-310 Impact of different degrees of genetic mosaicism in the kinetic profile of the human embryo. Presented at the 35th annual meeting of the European Society of Human Reproduction and Embryology, Vienna, Austria, 14-16 October 2019
- Simon C Gómez C Cabanillas S Vladimirov IK Castillón G Giles J Boynukalin FK Findikli N Ortega I Vidal C Izquierdo A Portela S Frantz N Taguchi S Labarta E Colucci F Mackens S Santamaría X Muñoz E Barrera SG Fernandez-Sanchez M O-134 IN VITRO FERTILIZATION WITH PERSONALIZED BLASTOCYST TRANSFER VERSUS FROZEN OR FRESH BLASTOCYST TRANSFER: A MULTICENTER, RANDOMIZED CLINICAL TRIAL. Presented at the 35th annual meeting of the European Society of Human Reproduction and Embryology, Vienna, Austria, 14-16 October 2019
- Vidal C Giles J Castillón G Martinez-Salazar J Fernandez L Ayllon Y Muñoz M Bellver J Tocino A Muñoz E Pellicer A Garrido N P-143 Intentional endometrial injury do not improve clinical outcomes in an oocyte donation program in patients without RIF. Interim analysis of a randomized controlled trial.. Presented at the 35th annual meeting of the European Society of Human Reproduction and Embryology, Paris, France, 14-16 October 2019
- Labarta E Mariani G Paolelli S Vidal C Giles J Bellver J Cruz F Marzal A Celada p Olmo I Alamá P Remohí J Bosch E O-173: A large prospective trial in unselected population confirms that low serum progesterone on the day of embryo transfer impairs pregnancy outcome in artificial cycles.. Presented at the 74th Scientific Congress & Expo of the American Society for Reproductive Medicine, Denver, CO, USA, 23-26 June 2019
- Bellver J Lathi RB Labarta E Vidal C Giles J Cabanillas S Marzal A Galliano D Marin C Ruiz-Alonso M Simón C Valbuena D Obesity affects endometrial receptivity by inducing a displacement of the personalized woi that after correction by personalized embryo transfer normalize clinical results. Presented at the 65th Annual Meeting of the Society for Reproductive Investigation, San Diego,CA,USA, October 6-10, 2018
- Labarta E Mariani Paolelli S Vidal C Giles J Marzal A Bellver J Cruz F Olmo I Alama P Celada P Bosch E Impact of serum progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles on the ongoing pregnancy rate. An interim analysis. Presented at the 73rd annual meeting of the American Society of Reproductive Medicine, San Antonio, Texas, October 6-10, 2018
Read more